Chris Lewis
Stock Analyst at Roth Capital
(3.03)
# 1,298
Out of 5,124 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $9.40 | -57.45% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $97.28 | -83.55% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $32.73 | -55.70% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $101.56 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.13 | +1,669.91% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $9.40
Upside: -57.45%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $97.28
Upside: -83.55%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $32.73
Upside: -55.70%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $101.56
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.13
Upside: +1,669.91%